查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1474893

MCED（多种癌症早期检测）市场规模、份额、趋势分析报告：按类型、最终用途、按地区、细分市场预测，2024-2030 年

Multi Cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

MCED（多种癌症早期检测）市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球MCED（多种癌症早期检测）市场规模将达到28.9亿美元，2024年至2030年复合年增长率为16.61%。

需要提供有效的方法来早期检测癌症，以便提供适当的治疗，以及癌症盛行率的上升和多种疾病类型预计将推动市场成长。对早期检测诊断的需求正在推动整个市场的发展，这有助于简单的疾病管理并降低随后的死亡率。

MCED（多发性癌症早期检测）测试旨在即使患者没有症状也能检测体内的肿瘤。同时评估多个讯号以确定您是否可能患有癌症。儘管已经开发出许多测试来早期检测癌症，但 MCED筛检测试直到最近才在美国成为第一个由实验室开发的测试。例如，2022 年 7 月，GRAIL 的 Galleri 成为圣路易斯 Mercy 的 LDT。此外，Exact Sciences 和 Freenome 正在开发 MCED筛检测试，而 GRAIL 的 Galleri 测试在销售时没有保险，因为能够检测多达 50 种不同的类型。

研究表明，MCED 测试在检测晚期和晚期阶段比早期阶段更敏感，早期阶段是可以治疗的，有时是可以治癒的。此外，该测试被发现具有高度特异性，这意味着未患有癌症的人测试呈阳性的可能性极小。 MCED 开发领域的研究仍在继续，以满足早期诊断的需求。

市场上的领先公司声称他们可以识别从几种癌症到 50 种癌症的任何类型。公司专注于发展和开发这些筛检测试，并更快地将其推向市场。例如，2020 年 12 月，Singra Genomics 筹集了 1.5 亿美元的 B 系列资金，用于开发、行销和推广其 MCED 测试。 GRAIL 与 Point32Health 开始了先导计画，使 Point32Health 成为第一个包含 MCED 测试的商业健康计划。

MCED（多种癌症早期检测）市场报告亮点：

  • 基因panel、LDT等细分领域引领市场，2023年占97.08%的份额。该领域的成长是由于诊断实验室使用 LDT 不需要 FDA核准。
  • 预计液态切片领域在预测期内将以最快的复合年增长率成长。该细分市场的成长是由于越来越多的参与者从投资者那里获得资金用于开发新测试。
  • 2023 年，医院终端用途领域以 48.44% 的份额引领市场。这是因为人们越来越倾向于住院治疗，因为他们可以在同一屋檐下获得各种服务。
  • 由于该地区癌症发生率高、技术进步快以及政府措施，2023 年北美多发性癌症早期检测市场将占 34.39% 的份额。
  • 由于医疗基础设施的显着改善、人口的成长以及进入市场的当地企业数量的增加，预计亚太地区 MCED（多发性癌症早期检测）市场将在预测期内呈现最快的复合年增长率。

目录

第一章 MCED（多发性癌症早期检测）市场：调查方法与范围

第 2 章 MCED（多发性癌症早期检测）市场：执行摘要

  • 市场展望
  • 分部展望
  • 竞争考察

第三章 MCED（多发性癌症早期检测）市场：产业展望

  • 市场体系展望
  • 市场动态
  • MCED（多种癌症早期检测）市场分析工具

第四章 MCED（多发性癌症早期检测）市场：类型估计和趋势分析

  • 类型市场占有率，2023年及2030年
  • 细分仪表板
  • 全球 MCED（多发性癌症早期检测）市场：按类型分類的展望
  • 2018-2030年市场规模、预测及趋势分析

第五章 MCED（多种癌症早期检测）市场：最终用途估计和趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 全球 MCED（多种癌症早期检测）市场：按最终用途分類的前景
  • 2018-2030年市场规模、预测及趋势分析

第六章 MCED（多发性癌症早期检测）市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018年至2030年市场规模、预测与趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • Illumina, Inc.（GRAIL, LLC）
    • Exact Sciences Corporation
    • FOUNDATION MEDICINE, INC.
    • AnchorDx
    • Guardant Health
    • Burning Rock Biotech Limited
    • GENECAST
    • Beijing Lyman Juntai International Medical Technology Development Co.
    • Freenome Holdings, Inc.
    • Elypta AB
Product Code: GVR-4-68039-966-1

Multi Cancer Early Detection Market Growth & Trends:

The global multi cancer early detection market size is expected to reach USD 2.89 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 16.61% from 2024 to 2030. The need for providing effective ways to detect cancer at an early stage so that the right treatment can be given and the rising prevalence of cancer and multiple forms are expected to fuel the growth of the market. The requirement for early detection diagnostics, which facilitates simple disease management and subsequently lowers the death rate, drives the overall market.

Multi cancer early detection (MCED) tests are designed to find tumors in the body even when a patient is asymptomatic. To determine whether there is a high probability that a person has cancer, they simultaneously evaluate several signals. Although numerous tests are being developed to detect cancer at an early stage, the first MCED screening test was just recently made available in the U.S. as a lab-developed test. For instance, in July 2022, GRAIL's Galleri was made available as an LDT at Mercy, St. Louis. Furthermore, MCED screening tests are being developed by Exact Sciences and Freenome, and GRAIL's Galleri test is being marketed without payer coverage with the claim that it can detect up to fifty different forms.

Studies show that MCED tests have a higher sensitivity for detecting later-stage or advanced than for detecting earlier stages, which are more treatable and occasionally curable. Additionally, it was found that the tests were highly specific, which made it extremely unlikely that they would give a positive result for someone who did not have cancer. To meet the demand for early diagnosis, ongoing research is still being done in the field of developing MCED.

The major players in the market assert that they can identify as few as two or three different cancer types or as many as fifty. They are focusing on the growth and development of these screening tests and faster commercialization. For instance, in December 2020, Singlera Genomics raised $150 million in Series B funding for the development, marketing, and promotion of its MCED tests. GRAIL launched a pilot project with Point32Health, making Point32Health the first commercial plan for health to include MCED tests.

Multi Cancer Early Detection Market Report Highlights:

  • The gene panel, LDT, & others segment led the market and accounted for a share of 97.08% in 2023. The growth of the segment is attributed to the non-requirement of FDA approval for the utilization of LDT in diagnostic laboratories.
  • The liquid biopsy segment is anticipated to grow at the fastest CAGR over the forecast period. The growth of this segment is attributed to the increasing number of players receiving funding from investors for the development of new tests.
  • The hospitals end-use segment led the market with a share of 48.44% in 2023. This is attributed to the growing preference of hospitals for care due to the availability of various services under one roof.
  • The North America multi cancer early detection market accounted for a share of 34.39% in 2023 owing to high cancer prevalence, rapid technological advancements, and the presence of various supportive government initiatives in the region.
  • Asia Pacific multi cancer early detection market is anticipated to witness the fastest CAGR over the forecast period due to a significantly improving healthcare infrastructure, a growing population, and a rising number of local companies entering the market.

Table of Contents

Chapter 1. Multi Cancer Early Detection Market: Methodology And Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Multi Cancer Early Detection Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End-Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Multi Cancer Early Detection Market: Industry Outlook

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Extensive R&D for the development of MCED
      • 3.2.1.3. Need to develop diagnostic options that can detect cancer at an early stage
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Collection of adequate safety and efficacy data for regulatory approval
  • 3.3. Multi Cancer Early Detection (MCED) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Multi Cancer Early Detection (MCED) Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Multi Cancer Early Detection (MCED) Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Liquid Biopsy
      • 4.4.1.1. Liquid biopsy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Gene Panel, LDT, and Others
      • 4.4.2.1. Gene panel, LDT, and others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Multi Cancer Early Detection (MCED) Market: End-use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Multi Cancer Early Detection (MCED) Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Diagnostic Laboratories
      • 5.4.2.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Other
      • 5.4.3.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Multi Cancer Early Detection (MCED) Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Illumina, Inc. (GRAIL, LLC)
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Exact Sciences Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. FOUNDATION MEDICINE, INC.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. AnchorDx
      • 7.3.7.1. Company overview
      • 7.3.7.2. Product benchmarking
      • 7.3.7.3. Strategic initiatives
    • 7.3.8. Guardant Health
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Burning Rock Biotech Limited
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. GENECAST
      • 7.3.10.1. Company overview
      • 7.3.10.2. Product benchmarking
      • 7.3.10.3. Strategic initiatives
    • 7.3.11. Beijing Lyman Juntai International Medical Technology Development Co.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Product benchmarking
      • 7.3.11.3. Strategic initiatives
    • 7.3.12. Freenome Holdings, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Product benchmarking
      • 7.3.12.3. Strategic initiatives
    • 7.3.13. Elypta AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Product benchmarking
      • 7.3.13.3. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 11 Europe multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Germany multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 17 France multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 23 Denmark multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 25 Sweden multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 27 Norway multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 China multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 32 China multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 36 India multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 South Korea multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 38 South Korea multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Australia multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 40 Australia multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Thailand multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 45 Latin America multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA multi cancer early detection market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 54 MEA multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait multi cancer early detection market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait multi cancer early detection market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Multi cancer early detection market: market outlook
  • Fig. 14 Tumor ablation competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Multi cancer early detection market driver impact
  • Fig. 20 Multi cancer early detection market restraint impact
  • Fig. 21 Multi cancer early detection market strategic initiatives analysis
  • Fig. 22 Multi cancer early detection market: Type movement analysis
  • Fig. 23 Multi cancer early detection market: Type outlook and key takeaways
  • Fig. 24 Liquid biopsy market estimates and forecast, 2018 - 2030
  • Fig. 25 Gene panel, LDT, & others estimates and forecast, 2018 - 2030
  • Fig. 26 Multi cancer early detection market: End-Use movement Analysis
  • Fig. 27 Multi cancer early detection market: End-Use outlook and key takeaways
  • Fig. 28 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 29 Diagnostic laboratories market estimates and forecasts,2018 - 2030
  • Fig. 30 Others market estimates and forecasts,2018 - 2030
  • Fig. 31 Global multi cancer early detection market: Regional movement analysis
  • Fig. 32 Global multi cancer early detection market: Regional outlook and key takeaways
  • Fig. 33 Global multi cancer early detection market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030
  • Fig. 45 U.S. key country dynamics
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 47 Canada key country dynamics
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 50 UK key country dynamics
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030
  • Fig. 52 Germany key country dynamics
  • Fig. 53 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 54 France key country dynamics
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy key country dynamics
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 58 Spain key country dynamics
  • Fig. 59 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 60 Denmark key country dynamics
  • Fig. 61 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 62 Sweden key country dynamics
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 64 Norway key country dynamics
  • Fig. 65 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 66 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 67 China key country dynamics
  • Fig. 68 China market estimates and forecasts, 2018 - 2030
  • Fig. 69 Japan key country dynamics
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 71 India key country dynamics
  • Fig. 72 India market estimates and forecasts, 2018 - 2030
  • Fig. 73 Thailand key country dynamics
  • Fig. 74 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 75 South Korea key country dynamics
  • Fig. 76 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 77 Australia key country dynamics
  • Fig. 78 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 79 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 80 Brazil key country dynamics
  • Fig. 81 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 84 Argentina key country dynamics
  • Fig. 85 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 87 South Africa key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 89 Saudi Arabia key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 91 UAE key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 93 Kuwait key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 95 Market share of key market players- Multi cancer early detection market